Having the difference in tumor frequency between the ubiquitous and promoter specific models suggests that there might also be other cells of origin, which do not express Sox2 during tumor initiation and thus cannot be detected by our Sox2-cre models. The gene discussed is SOX2; the disease is neoplasm.